Kelloff Gj
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Cancer Genomics and Diagnostics 2
- Cancer, Lipids, and Metabolism 2
- Genetics 4
- Estrogen and related hormone effects 2
- Co-authors
- L.J. Esserman (1 shared paper)DA Berry (1 shared paper)NM Hylton (1 shared paper)Peter Greenwald (5 shared papers)Marjorie G. Perloff (1 shared paper)Alberts Ds (4 shared papers)Ronald Lieberman (1 shared paper)Crawford Ed (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (2 papers)Prostate Cancer and Prostatic Diseases (1 paper)PubMed (15 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Kelloff Gj
18 papers receiving 849 citations
Kelloff Gj's Hit Papers
Peers
Comparison fields: 5 of 93
- Statistics and Probability 213
- Cancer Research 302
- Oncology 181
- Biochemistry 38
- Pathology and Forensic Medicine 75
Countries citing papers authored by Kelloff Gj
This map shows the geographic impact of Kelloff Gj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelloff Gj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelloff Gj more than expected).
Fields of papers citing papers by Kelloff Gj
This network shows the impact of papers produced by Kelloff Gj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelloff Gj. The network helps show where Kelloff Gj may publish in the future.
Co-authors
The 12 scholars most cited alongside Kelloff Gj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy Hit paper breakdown → | 2009 | 596 |
| 2 | Strategies for identification and clinical evaluation of promising chemopreventive agents. | 1996 | 48 |
| 3 | 2017 | 40 | |
| 4 | Clinical development plan: N-(4-hydroxyphenyl)retinamide. | 1994 | 39 |
| 5 | Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone. | 1994 | 33 |
| 6 | The role of chemoprevention in cancer control. | 1996 | 26 |
| 7 | Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. | 1994 | 23 |
| 8 | 1999 | 23 | |
| 9 | Biomarker end-points in cancer chemoprevention trials. | 1997 | 19 |
| 10 | Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse. | 1973 | 13 |
| 11 | Animal models for chemoprevention of respiratory cancer. | 1992 | 12 |
| 12 | Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis. | 1998 | 8 |
| 13 | Screening of potential cancer preventing chemicals as aromatase inhibitors in an in vitro assay. | 1999 | 8 |
| 14 | Modulation of Ki67, p53 and RARbeta expression in normal, premalignant and malignant human oral epithelial cells by chemopreventive agents. | 2002 | 4 |
| 15 | Clinical development plan: beta-carotene and other carotenoids. | 1994 | 4 |
| 16 | Clinical development plan: 18beta-glycyrrhetinic acid. | 1994 | 3 |
| 17 | Clinical development plan: Proscar. | 1994 | 3 |
| 18 | Screening of potential cancer preventing chemicals as antioxidants in an in vitro assay. | 1998 | 2 |
About Kelloff Gj
Kelloff Gj is a scholar working on Cancer Research, Genetics, Statistics and Probability, Oncology and Pathology and Forensic Medicine, having authored 18 papers that have together received 904 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Statistical Methods in Clinical Trials (2 papers), Estrogen and related hormone effects (2 papers), Retinoids in leukemia and cellular processes (2 papers), Cancer, Lipids, and Metabolism (2 papers), Genetic factors in colorectal cancer (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Animal Virus Infections Studies (1 paper). The work is most often cited by research in Statistics and Probability (213 citations), Cancer Research (302 citations), Oncology (181 citations), Biochemistry (38 citations) and Pathology and Forensic Medicine (75 citations). Kelloff Gj has collaborated with scholars based in United States and Canada. Frequent co-authors include L.J. Esserman, DA Berry, NM Hylton, Peter Greenwald, Marjorie G. Perloff, Alberts Ds, Ronald Lieberman, Crawford Ed, Fernand Labrie and Rao Kv. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Prostate Cancer and Prostatic Diseases and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.